GW-468816

DB15099ExperimentalSmall molecule

GW-468816 is under investigation in clinical trial NCT00218465 (Effectiveness of GW468816, an NMDA Glycine Site Antagonist, for Prevention of Relapse to Smoking).

Chemical structure of GW-468816
Formula / weight
C20H17ClN2O3 ยท 368.82 g/mol (avg)
Code names
GW-468816

Resolves to

Compound
UNII3WGI8FOO62CAS476689-77-7ChEMBLCHEMBL1206161
Structure
InChIKeyXDKRVNKVAKCFGW-WXWBBQJKSA-NSMILESOC(=O)[C@H]1C\C(=C2\CCN(C2=O)C2=CC=CC=C2)C2=CC=C(Cl)C=C2N1

Which companies are running trials of GW-468816, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In